MAIA Biotechnology, Inc. (MAIA) Stock

MAIA Biotechnology, Inc. (MAIA) is a Healthcare stock trading at $1.39 (as of 2026-06-18), with a market capitalization of $84.51M and a trailing P/E of -2.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

MAIA Biotechnology, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of cancer therapies, primarily for non-small cell lung cancer. Its lead investigational candidate, THIO, is designed around telomere targeting and immunogenicity. The company is based in Chicago and was founded in 2018.

Valuation — source: SEC EDGAR (first-party)
Price$1.39
Market Cap$84.51M
P/E Ratio-2.1
Price / Book3.07
Price / Sales2897.34
DCF Value (model)$-5.29
DCF Upside vs Price-480.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$0.00
Return on Equity-87.3%
Current Ratio5.59
Valuation vs Sector & Industry
Stock P/E-2.1
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-109.9%
vs Industry-112.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderSolas Capital Management, LLC ($6.02M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOVlad Vitoc
Employees13
CountryUS
IPO Date2022-07-28

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Voyager Acquisition Corp. (VACH)
  • MIRA Pharmaceuticals, Inc. (MIRA)
  • Clene Inc. (CLNN)
  • ALX Oncology Holdings Inc. (ALXO)
  • Metagenomi, Inc. Common Stock (MGX)
  • Cumberland Pharmaceuticals Inc. (CPIX)
  • Aligos Therapeutics, Inc. (ALGS)
  • Assertio Holdings, Inc. (ASRT)
MAIA earnings history · MAIA institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.